You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys CA 19-9 IVD Elecsys® CA 19-9 CPS_000449 11 776 193 214 11776193214 CA 19-9 Elecsys cobas e 100 Elecsys CA 19-9 07613336162866 Reagents, kits 100 tests cobas e 411/601/602 true 07 027 028 214 7 027 028 214 07027028214 7027028214 07027028214 CA 19-9 Elecsys E2G 300 Elecsys CA 19-9 07613336194102 Reagents, kits 300 tests cobas e 402/801 true 11776193500 Elecsys CA 19-9 en 26 FF00000004FC260E FF0000000032CB0E 11776193122 11776193214 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 19‑9 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 11776193500 Elecsys CA 19-9 en 27 FF00000006AF100E FF00000004FC260E 11776193122 11776193214 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use
Immunoassay for the in vitro quantitative determination of CA 19‑9 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027028500 Elecsys CA 19-9 en 8 FF00000006AF0F0E FF000000045D600E 07027028190 07027028214 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 19‑9 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en